Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)

被引:127
|
作者
Maltezou, H. C. [1 ]
Giakkoupi, P. [2 ]
Maragos, A. [1 ]
Bolikas, M. [3 ]
Raftopoulos, V. [1 ]
Papahatzaki, H. [3 ]
Vrouhos, G. [4 ]
Liakou, V. [3 ]
Vatopoulos, A. C. [2 ]
机构
[1] Hellen Ctr Dis Control & Prevent, Dept Intervent Health Care Facil, Athens, Greece
[2] Natl Sch Publ Hlth, Dept Microbiol, Athens, Greece
[3] Venizeleio Gen Hosp, Dept Microbiol, Iraklion, Greece
[4] Venizeleio Gen Hosp, Intens Care Unit, Iraklion, Greece
关键词
KPC; Carbapenemase; Resistance; Nosocomial outbreak; Klebsiella pneumoniae; Tigecycline; Colistin; HYDROLYZING BETA-LACTAMASE; KPC-2; ISOLATE; TIGECYCLINE; SPP;
D O I
10.1016/j.jinf.2009.01.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Starting in May 2007, an ongoing outbreak of infections due to carbapenem resistant KPC-2-producing Klebsiella pneumoniae occurred in a tertiary care hospital in Crete (Greece). The outbreak involved 22 patients, none of whom had travelled in a country with known high prevalence of such isolates. KPC-producing K. pneumoniae strains were mainly isolated from patients admitted in the Intensive Care Unit, on mechanical ventilation, with prolonged hospitalization, prolonged administration of antibiotics, and prolonged administration of carbapenems. Clinical diagnoses were: pneumonia (62% of cases), surgical site infection (19%), bacteremia (9.5%), urinary tract infection (4.7%), and peritonitis (4.7%). Overall, 61 KPC-producing K. pneumoniae isolates were recovered, mainly from the respiratory tract (59.1%), catheter tip (22.7%), surgical site (18.2%), and blood (18.2%). Among 16 patients for whom therapeutic data were available, 14 (87.5%) were treated with a combination of colistin and/or tigecycline and/or garamycin. Clinical failure was noted in 22.2% of 18 patients available for assessment of clinical outcome, and microbiologic failure in 87.5% of 8 patients available for assessment of microbiologic outcome. In conclusion, an outbreak of KPC-producing K. pneumoniae infections has occurred in a tertiary care hospital in Greece, with significant associated morbidity and mortality. Prospective studies are required to evaluate the available therapeutic options for these infections. Our efforts should focus on rational use of available antibiotics, enhancement of infection control measures, and implementation of active antibiotic resistance surveillance. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:213 / 219
页数:7
相关论文
共 50 条
  • [1] Occurrence of KPC-2-producing Klebsiella pneumoniae strains in hospital wastewater
    Chagas, T. P. G.
    Seki, L. M.
    da Silva, D. M.
    Asensi, M. D.
    JOURNAL OF HOSPITAL INFECTION, 2011, 77 (03) : 281 - 281
  • [2] KPC-2-PRODUCING KLEBSIELLA PNEUMONIAE INFECTIONS IN GREEK HOSPITALS ARE MAINLY DUE TO A HYPEREPIDEMIC CLONE
    Giakoupi, P.
    Maltezou, H.
    Polemis, M.
    Pappa, O.
    Saroglou, G.
    Vatopoulos, A.
    EUROSURVEILLANCE, 2009, 14 (21): : 69 - 73
  • [3] KPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil
    Biberg, Camila Arguelo
    Souza Rodrigues, Ana Claudia
    do Carmo, Sidiane Ferreira
    Volpe Chaves, Claudia Elizabeth
    Gales, Ana Cristina
    Chang, Marilene Rodrigues
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2015, 46 (02) : 501 - 504
  • [4] First Outbreak of KPC-2-Producing Klebsiella pneumoniae Sequence Type 258 in a Hospital in South Korea
    Hong, Sung Kwan
    Yong, Dongeun
    Kim, Kyeongmi
    Hong, Sang Sook
    Hong, Seong Geun
    Khosbayar, Tulgaa
    Song, Wonkeun
    Roh, Kyoung Ho
    Jeong, Seok Hoon
    Lee, Kyungwon
    Chong, Yunsop
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (11) : 3877 - 3879
  • [5] Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction
    Ducomble, T.
    Faucheux, S.
    Helbig, U.
    Kaisers, U. X.
    Koenig, B.
    Knaust, A.
    Luebbert, C.
    Moeller, I.
    Rodloff, A. C.
    Schweickert, B.
    Eckmanns, T.
    JOURNAL OF HOSPITAL INFECTION, 2015, 89 (03) : 179 - 185
  • [6] The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae
    Tang, Hung-Jen
    Chen, Chi-Chung
    Lu, Ying-Chen
    Huang, Hui-Ling
    Chen, Hung-Jui
    Chuang, Yin-Ching
    Lai, Chih-Cheng
    Chao, Chien-Ming
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [7] Characterization of KPC-2-producing Klebsiella pneumoniae and affected patients of a pediatric hospital in Brazil
    Barroso, Marlon do Valle
    da Silva, Caroline R.
    Benfatti, Luisa R.
    Gozi, Katia S.
    de Andrade, Letcia K.
    Andrade, Leonardo N.
    Estofolete, Cassia F.
    Nogueira, Mara C. L.
    Casella, Tiago
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 106 (02)
  • [8] Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: The role of clinical management
    Delory, T.
    Seringe, E.
    Antoniotti, G.
    Novakova, I.
    Goulenok, C.
    Paysant, I.
    Boyer, S.
    Carbonne, A.
    Naas, T.
    Astagneau, P.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (10) : 1070 - 1075
  • [9] KPC-2-producing Klebsiella pneumoniae ST11 in a Children's Hospital in Poland
    Machulska, Monika
    Baraniak, Anna
    Zak, Iwona
    Bojarska, Katarzyna
    Zabicka, Dorota
    Sowa-Sierant, Iwona
    Hryniewicz, Waleria
    Gniadkowski, Marek
    POLISH JOURNAL OF MICROBIOLOGY, 2017, 66 (03) : 401 - 404
  • [10] First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil
    Monteiro, Jussimara
    Santos, Anderson Fernandes
    Asensi, Marise Dutra
    Peirano, Gisele
    Gales, Ana Cristina
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) : 333 - 334